VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,488,6521,702,1771,032,336
Cost of Revenue275,119210,460124,512
Gross Profit2,213,5331,491,717907,824
Operating Expenses
Research Development1,324,6251,047,690995,922
Selling General and Administrative496,079432,829376,575
Non Recurring269,5861,2622,206
Total Operating Expenses---
Operating Income or Loss123,2439,936-466,879
Income from Continuing Operations
Total Other Income/Expenses Net-81,3824,130-6,715
Earnings Before Interest and Taxes41,86114,066-473,594
Interest Expense57,55081,43284,206
Income Before Tax-15,689-67,366-557,800
Income Tax Expense-107,32416,66530,381
Minority Interest13,727181,609153,661
Net Income From Continuing Ops263,484-112,052-556,334
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income263,484-112,052-556,334
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares263,484-112,052-556,334